Xeris Biopharma Holdings Inc - XERS - stock price prediction, stock price target, analyst ratings from 6 analysts

Xeris Biopharma Holdings Inc has a share price target of US$ 9, revenue growth forecast of 41.1%, and profit growth estimate of 91.6% for FY25, based on top 6 analyst calls.